Objectives: Hemolysis is a significant complication of extracorporeal membrane oxygenation (ECMO), with a reported incidence of 12.2%. The aims of this study were (1) to investigate hemolysis caused by saline-washed versus unwashed RBCs, (2) to determine in vitro the effects of saline washing on erythrocyte hemolytic markers and (3) to investigate hemolysis by centrifugal versus roller pumps.
Introduction
Hemolysis remains one of the most serious problems occurring after extra corporeal membrane oxygenation (ECMO) in the neonatal intensive care unit (NICU), with an incidence of 12.2% according to the Extracorporeal Life Support Organization (ELSO) registry in their January 2005 report. Hypothetically, two major causes for hemolysis might be 1 the practice of pre-washing blood, or 2 the use of centrifugal pumps during ECMO. Therefore, the aims of this study were (a) to compare the extent of hemolysis in ECMO patients transfused with washed versus unwashed RBCs, (b) to determine in vitro the effects washing on erythrocyte membrane integrity and (c) to compare the incidence of hemolysis using centrifugal versus roller pumps.
Methods

Clinical review
We obtained approval from our institutional review board to conduct a retrospective review of the medical charts of all ECMO patients cared for in our level III NICU from April 1996 to October 2005 (n ¼ 60). In May 2001, a change in NICU policy had been implemented to stop saline washing of RBCs for ECMO. This change effectively divided our ECMO population into an earlier washed group (n ¼ 31) that received saline-washed RBCs to prime the ECMO circuit and for subsequent blood transfusions, and a later unwashed group (n ¼ 29) that received only unwashed RBCs. During both periods, all patients were treated with veno-arterial bypass, using a Medtronic membrane oxygenator and a Biomedicus centrifugal pump. Otherwise, the same protocol was followed for the conduct of all phases of ECMO. As markers of hemolysis, peak plasma-free hemoglobin (FHb) and serum total bilirubin (TB) from days 1 to 3 were compared with that from days 4 to 7 of ECMO or at the end of the ECMO period, if lasting less than 7 days.
In vitro study Fourteen units of RBCs were saline-washed using a compact-advanced cell separator (Dideco; Mirandola, Italy). Each unit was washed with 1 l of 0.9% sodium chloride and centrifuged at 2000 g. Twenty milliliter aliquots were drawn off for analysis immediately before and after saline washing for baseline analysis (hour 0). Aliquots were transferred to smaller tubes, and promptly sent to the clinical lab for FHb determination (there the plasma was separated from the blood within 6 h of arrival). The remaining blood from both samples (washed and unwashed) was then refrigerated at 41C for 4 h before analysis. A 4-h period was chosen as this is the maximum time allowed for stored blood to be transfused following release from our institutional blood bank. The baseline percent hemolysis of the washed and unwashed group were determined as soon as possible at 0 h and after 4 h. Briefly, individual blood cell samples of each group were exposed for 30 min to three concentrations of buffered sodium chloride (NaCl) solutions of 0.85, 0.50 and 0.05%. After centrifugation at 600 g for 5 min, the percent of osmotically induced hemolysis was assayed spectrophotometrically at 540 nm and the results expressed as:
, where A(0.5%) is the absorbance at NaCl concentration 0.5%, A(0.05%) is the absorbance in 0.05% NaCl and A(0.85%) is the absorbance in 0.85% NaCl.
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ELSO database analysis and survey Although ELSO was formed in 1989, the registry began in 1975 as an international database of ECMO patients, and it has been actively maintained since 1984. With approval from ELSO, we reviewed the de-identified data on all neonatal ECMO cases reported from 1994 to 2004. Specifically, we noted the type of ECMO pump utilized by each center and the presence or absence of hemolysis. In the ELSO registry, hemolysis is recorded as having occurred or not, with no specific definition. In addition to the above retrospective survey, a telephone survey of all active ECMO centers was conducted between February and May 2005 in an effort to obtain more precise and more current information on the practice of saline washing of blood, and to determine whether FHb was routinely followed as a measure of hemolysis. Specifically, we asked a member of each ECMO specialist team: (1) 
Statistical analyses
Statistical analyses were conducted using the w 2 -test for bivariate comparisons. The non-parametric Mann-Whitney U-test was used for intergroup comparisons of plasma markers of hemolysis, whereas the Spearman's r-correlation test was used to assess bivariate correlations. Paired and unpaired t-tests and the Wilcoxon signed-rank and Mann-Whitney U-tests were used for intragroup and intergroup comparisons of parametrically and non-parametrically distributed variables, respectively. For all, P<0.05 was considered significant.
Results
Clinical study
There were 60 ECMO cases in our NICU during the study period. Similar gestational ages, birth weights, duration of ECMO and primary diagnoses were noted between the retrospective patient cohorts separated into unwashed and washed groups ( Table 1) . Peak FHb was significantly lower (P ¼ 0.03) in the unwashed blood group compared with the washed cohort during the first 3 days after ECMO, but this difference disappeared from the 4th to 7th day of ECMO (Table 2) . Concurrently, the peak serum TB of the unwashed blood group was significantly lower during the first 3 days post-ECMO (P ¼ 0.02) and, in contrast to FHb levels, was also significantly lower between day 4 to 7 (P ¼ 0.03) after ECMO compared with levels of the washed blood group. Several other factors that might contribute to hemolysis, such as cannula size and ECMO flow rate, did not correlate with FHb concentrations, either after 3 or 7 days of ECMO (data not shown).
In vitro erythrocyte membrane osmotic fragility
Fourteen units of RBCs were tested. The mean age of these units was 12.8 days (range: 2-28 days), and all units were stored at 41C until the time of analysis. K þ and Hb levels were significantly lower in the washed blood samples immediately after washing (P ¼ 0.004 for K þ ; P ¼ 0.001 for Hb). This difference persisted after 4 h at 41C (P ¼ 0.02 for K þ ; P ¼ 0.01 for Hb; Table 3 ). There was no significant difference in the K þ levels of the unwashed cells due to 4 h storage at 41C (22.9 versus 17.8, P ¼ 0.15), but there was a significant difference in the K þ levels of the washed cells due to 4 h of storage at 41C (4.8 versus 5.5, P ¼ 0.036). The differences in the FHb levels were insignificant between washed and unwashed samples or between 0 and 4 h samples. When subjected to 0.5% buffered NaCl, washed RBCs displayed significantly lower membrane osmotic fragility than unwashed blood (P ¼ 0.004) at zero hours, but this difference disappeared after 4 h at 41C. Whereas unwashed RBCs did not show any significant increase in fragility between 0 and 4 h, washed RBCs showed a significant increase in fragility (P ¼ 0.04; Figure 1 ).
ELSO registry analysis and survey
There were 10 242 ECMO procedures reported during the study period. Data on the type of pump system used were available for 10 013 ECMO procedures (97.8%). These results are summarized in Table 4 . Roller pumps were used for the majority (n ¼ 9375) of patients (93.6%). Hemolysis was reported in 1361 (13.6%) of all ECMO procedures, of which 1030 cases occurred with the roller pump and 325 cases with the centrifugal pump. Thus, 11% of patients using a roller pump experienced hemolysis, whereas this incidence rose to 59% for infants treated with centrifugal pumps (Pp0.05). Though we attempted to survey 100 active American ECMO centers, only 49 responded. Twenty-five (51%) of responding centers washed blood for ECMO, indicating that RBC washing is still a common practice. Only 26 (53%) of the responding centers routinely measured FHb as a marker of hemolysis. There was also a wide variability in the frequency of FHb determinations, ranging from every 6 h to once a day or after 7 days, and in some cases, only if clinical signs of hemolysis were apparent. For those centers that did not measure FHb, respondents indicated clinical findings such as hematuria were used as indicators of hemolysis. Technical difficulties such as a lengthy laboratory processing time or a lack of availability of the test at their institution were reported as obstacles to the use of FHb. 
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Discussion
We found that 13.6% of ECMO result in RBC hemolysis that may adversely affect morbidity and long-term outcome. Hemolyzed RBCs release non-protein bound free iron that is implicated in poor neurodevelopment. 2, 3 In addition, high total plasma bilirubin has been associated with kernicterus, although this association is not as clear-cut as the association of plasma-free bilirubin with neurotoxicity. 4 These concerns led us to investigate variables pre-and during ECMO that might affect RBC hemolysis after ECMO, namely the saline pre-washing of the blood used for the ECMO, and the kind of pump used during ECMO. Neonatal plasma FHb was followed for 1 week after being on ECMO, because it is a reliable measure of the degree of hemolysis. 5, 6 Our findings that peak FHb was significantly lower in the unwashed blood group compared with the washed cohort during the first 3 days of ECMO, and that this difference disappeared on the 4th-7th day on ECMO, may have been due to the liver clearing the plasma of the excess FHb released by the washed cells. Therefore, using unwashed blood for ECMO may remove a subsequent added burden for the liver caused by transfused erythrocyte hemolysis.
We also collected serum TB values, the biomarker we use to manage neonatal bilirubin levels in accordance with current AAP recommendation. 7 Wennberg et al. 4 eloquently argue that free bilirubin is the more sensitive biomarker for neurotoxicity; however, testing free bilirubin was not practical in our study. Even though the etiology of elevated serum bilirubin in these critically ill infants is multifactorial, 8 the significant elevation of peak serum TB that coincided with an elevation of FHb in the first 3 days of ECMO, and, in addition, the persistence of significantly higher TB levels from day 4 to day 7 after ECMO in the washed blood group, justifies the conclusion that unwashed blood is safer than washed blood, and less likely to result in subsequent harmful sequelae.
Two conjectures have been used to justify saline washing of RBCs before their use in ECMO. It has been postulated that washing removes debris, nonviable cells and unspecified metabolic breakdown products, thereby reducing possible sources of toxicity by removing supernatant hemoglobin, leukocytes and plasma. [9] [10] [11] Also, when older units of blood are used in massive transfusions, saline washing has been employed in an effort to reduce the risk of hyperkalemia. This latter rationale has been challenged, particularly when applied to less-than-massive volumes of blood transfused, because when small volumes are transfused, the major consideration for the patient is the total amount of K þ transfused and the transfusion rate. 12, 13 During ECMO, the transfusion volume is sufficiently small and the blood is infused sufficiently slow that it probably completely mixes with the patient's blood volume, resulting in little, if any, increase of in vivo plasma K þ levels. In vitro we found that saline washing does reduce [K þ ], and it is still significantly lower in the washed group than the unwashed group after 4 h at 41C (Table 3) , but washing also hemolyzes erythrocytes (see Hb levels; Table 3 ), and leaves the remaining erythrocytes more prone to lyse, causing increased plasma FHb levels the first 3 days post-ECMO. All things considered, the clinical advantage of the possible lowering of K þ by washing is probably more than offset by the increased hemolysis of the washed RBCs that was observed in the increase in plasma FHb during the first 3 days after ECMO.
Saline washing also decreased hemoglobin indicating that fewer cells remained in the washed blood than in the unwashed blood ( Table 3 ). The washing procedure had purged 'old and weak' red cells that were prone to hemolysis, and the remaining cells that survived the washing were understandably less osmotically fragile immediately after the wash, but their membrane integrity had been compromised by washing and by removal of the buffered glucose the blood had been collected in. This was shown by their increased hemolysis after 4 h of storage ( Figure 1 ). The significant increase of hemolysis in only the washed group after being stored for 4 h at 41C, implies that washed red blood cells have a higher rate of hemolysis than the unwashed cells during storage and other kinds of stress before and after being transfused into the patient's body. Thus, our in vitro findings, provide a physiologic explanation for the in vivo observation of increased hemolysis owing to saline washing. Additionally, the dilution (lower hemoglobin) of the washed cells necessitates the transfusion of a larger volume of blood from washed RBCs than unwashed RBCs, given the need to maintain patients hemoglobin at or above a certain threshold level during ECMO, further exacerbating the mass of membranecompromised RBCs per patient receiving washed blood.
Our in vitro data reflected our in vivo data to the extent that washed cells were more apt to hemolyze under stress as shown in vitro when the stress was storage without glucose at 41C, and as shown in vivo from the stress of both storage and transfusion. Thus, we would consider this model to be worth pursuing if more evidence of specific effects of saline washing of blood were desired. For example, the effect of saline washing on the concentration of blood cell 2,3-diphosphoglycerate (DPG) could more ethically be determined in vitro than in vivo. The level of DPG within the red cell is especially important in hemoglobin oxygenation. Hemoglobin is an extremely inefficient oxygen transporter without DPG, because without DPG, hemoglobin releases only 8% of its cargo to the tissues.
14 Thus, the level of red cell DPG bears directly on the efficiency of oxygen transport to the tissues, which is critical to the clinical situation. If washing were found to lower DPG levels, as would be predicted, the contraindication of saline washing for blood ECMO would be reinforced.
In addition to saline pre-washing of blood, another cause of hemolysis is the pump that is used during ECMO. [15] [16] [17] Our collection of ELSO registry data from 1994 to 2004 documented that 94% of ECMO centers use roller pumps, a percentage also found for an independent review for 2002. 18 Our analysis compared hemolysis after the use of either of the two pump types and found that hemolysis occurred more often in patients supported by centrifugal pumps as compared with roller pumps, although admittedly, this observation is weakened by the lack of a uniform definition of hemolysis. Given the possible relationships described above between hemolysis and outcome, we want to emphasize the need to determine FHb and other related hemolytic parameters on all ECMO neonates.
In spite of concerns for increased hemolysis, the centrifugal pump is still favored over the roller pump by some because of several concerns: (1) the centrifugal pump requires smaller priming blood volume within a smaller circuit, possibly reducing the chance of a plastic-mediated host inflammatory response, (2) the centrifugal pump is less occlusive, thus generates lower pressures in response to sustained or transient downstream occlusion, hence lowering the risk of tubing rupture, and (3) the centrifugal pump's more compact configuration makes it more suitable to use in transport. 19, 20 However, prudence dictates that in view of the much higher incidence of dangerous hemolysis using the centrifugal pump (59 versus 11%), attempts be made to design a pump to use less volume, to be less occlusive and to be more compact. Our in vitro testing model might be useful in comparing new pump designs especially if the difference in hemolysis caused by centrifugal versus roller pumps could be established in vitro as standards of comparison.
In sum, data from our NICU indicate that stopping the practice of saline washing of RBCs before transfusion decreases harmful hemolysis. These in vivo findings were compatible with our in vitro findings, so that variables affecting hemolysis in vivo might, in the future, be reliably examined in vitro. Our survey found centrifugal pumps to cause more hemolysis than roller pumps. We conclude that the hemolysis commonly observed during ECMO can be significantly reduced independently by the use of unwashed blood or by the use of roller pumps. These findings support the need for further research and for reform of current practices. We call for all ECMO centers to determine FHb levels routinely and to collect and share their data in a collaborative effort to reduce the risk of hemolysis in ECMO neonates.
